Navigation Links
Sosei Signs Definitive Distribution Agreement With ASKA for Commercialisation of SOH-075 (NorLevo(R))
Date:11/2/2009

TOKYO, November 2 /PRNewswire-FirstCall/ -- Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565), the biopharmaceutical company, today announced that Sosei Co., Ltd., its wholly owned Japanese subsidiary, has entered into a definitive distribution agreement with ASKA Pharmaceuticals Co., Ltd. ("ASKA", TSE First Section Index: 4514) for the commercialisation of the emergency contraceptive pill SOH-075 (NorLevo(R)).

NorLevo(R) is an oral emergency contraceptive "morning after pill" which is used to prevent unwanted pregnancy after unprotected intercourse. NorLevo(R) contains only levonorgestrel as an active ingredient. The dosing is started within 72 hours after unprotected sexual intercourse. NorLevo(R) was first launched in Europe in 1999 and is currently approved in some 60 countries, the product being both safe and effective as an oral emergency contraceptive for post-coital use.

Sosei have acquired the exclusive distribution rights to the product in Japan from HRA Pharma. The NDA application for SOH-075 was submitted in Japan in September 2009.

The agreement is based on the terms of a binding letter of agreement that was announced on 22 October 2008. According to this agreement, Sosei is responsible for development and registration and ASKA for sales and marketing.

In accordance with the agreement, Sosei will receive upfront, milestone payments as well as a margin on product sales to ASKA.

Notes for Editors:

About Sosei

Sosei is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan. For further information
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Sosei Announces Completion of Phase III Trial for NorLevo(R)
2. Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting
3. Sosei Confirms the Safety of SD118 in Two Phase I Trials
4. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
5. Sosei Assigns AD 923 Assets to Pharmasol
6. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
7. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
9. New Anti-TNF Golimumab Significantly Reduced Signs and Symptoms of Ankylosing Spondylitis According to Phase 3 Study Findings
10. New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema
11. ALS Therapy Development Institute Signs Collaboration Agreement with the Allen Institute for Brain Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oct 22, 2014 Antigen Discovery Inc. (ADi), ... , announced the receipt of a National Institutes ... (SBIR) from the National Institute of Dental and Craniofacial Research ... of a Pan-HIV Protein Microarray Chip, which will contain ... subtypes and aid in the development of safe and ...
(Date:10/22/2014)... , Oct. 22, 2014   Reproductive ... world-renowned leader in the field of infertility, presents ... to embryonic screening. The research abstract, released during ... Reproductive Medicine (ASRM) meeting in Honolulu, ... and single gene defect (SGD) pre-implantation genetic diagnosis ...
(Date:10/22/2014)... 2014  Paper Pak Industries, a manufacturer of ... Body Guard Bio, a disposable, highly absorbent ... and virus while protecting service providers and the ... a rugged, external nylon shell, watertight zipper, thermal ... inner chamber that contains contaminated and potentially contagious ...
Breaking Medicine Technology:Biomarker Discovery Company, Antigen Discovery Inc., Awarded an NIH Phase I Small Business Innovation Research Grant to Develop a Pan-HIV Protein Microarray Chip 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 2New IVF Research Highlights Improved Genetic Screening Approach To Help Parents Have Healthier Babies 3New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2
... 2012 Pharmalink AB, today announces it ... of new shares to the Company,s existing shareholders, including ... to further advance Nefecon® and Busulipo™, Pharmalink,s two lead ... developed for patients with IgA nephropathy, the most common ...
... VILLAGE, Nev., Jan. 3, 2012 PDL BioPharma, Inc. (PDL) ... preliminary results of its offer to exchange up to $180,000,000 ... due 2015 (Old Notes), for a like principal amount of ... Notes), and a cash payment.  The name of the New ...
Cached Medicine Technology:Pharmalink AB Raises SEK 35 Million Through Share Issue 2PDL BioPharma Announces Expiration and Preliminary Results of its Exchange Offer 2
(Date:10/25/2014)... October 25, 2014 Homeowners that are ... ‘gone bad’ need wonder no more. Clean Crawls ... should watch out for when it comes to insulation ... to the article released by Clean Crawls, can cause ... that any insulation that has deteriorated, become damp, or ...
(Date:10/25/2014)... Reinberg HealthDay Reporter FRIDAY, ... common cold sores -- herpes simplex -- might increase the ... In fact, being a carrier of certain antibodies to ... researchers found. "The identification of a treatable cause ... breakthrough," said lead researcher Dr. Hugo Lovheim, an associate professor ...
(Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. ... developed that spot increased risks for certain cancers, one might ... screened. But a new study suggests that, at least ... found out their genes doubled their risk of colon cancer ... get screened. "It didn,t make any difference, not at ...
(Date:10/22/2014)... Medical Solutions , the ... to announce that our co-founder and CFO, Scott ... Staffing 100 for 2014. Anderson was also named ... people in the staffing industry,” in 2013.     , ... healthcare staffing company in the U.S., was named ...
(Date:10/22/2014)... Lexington, Kentucky (PRWEB) October 22, 2014 ... an agreement that will change the current location of ... Road to South Limestone across from the University of ... be a state-of-the-art ambulatory care center, owned and operated ... meet the orthopaedic needs of children and their families ...
Breaking Medicine News(10 mins):Health News:5 Signs Indicating That Insulation Needs Replacing as Told By Clean Crawls in Recent Article 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Knowing Genetic Risk for Cancer May Not Change Behavior 2Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 2Health News:Medical Solutions Co-Founder/CFO Scott Anderson Named to Staffing Industry Analysts’ 2014 Staffing 100 3Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 2Health News:Shriners Hospitals for Children - Lexington Announces Plan to Build New $47 Million Facility 3
... their families may not understand the different meanings and ... ordersHARRISBURG, Pa., Jan. 12 More than 200 events ... show that healthcare providers, patients and their family members ... living wills and DNR (do not resuscitate) orders which ...
... susceptibility for skin cancer in mice. In the process, they have identified ... this susceptibility. The technique, the scientists say, could be used to ... ... -- UCSF researchers have used a new strategy to study ...
... (Nasdaq: CYBX ) today announced that ... President, Research and Development, effective on January 12, ... the company,s development programs. Dr. Morris joins Cyberonics ... technology company in North Carolina, where he has ...
... /PRNewswire/ - - A new report shows that Delta ... a position the nation,s largest dental benefit system has held ... independent firm that provides data on providers and managed care ... network has more than 123,000 dentists, totaling more than 62,000 ...
... Half of working Americans with health insurance surveyed ... health insurance covers for medical expenses related to cancer treatment. ... covered by health insurance conducted online by Harris Interactive on ... , ...
... and SAN FRANCISCO, Jan. 12 WeissComm Group, ... independent communications agency focused exclusively on the healthcare ... helping companies build health-based brands, today announced the ... that works with healthcare and technology companies to ...
Cached Medicine News:Health News:Pennsylvania Patient Safety Authority Releases December Advisory 2Health News:Pennsylvania Patient Safety Authority Releases December Advisory 3Health News:Pennsylvania Patient Safety Authority Releases December Advisory 4Health News:Pennsylvania Patient Safety Authority Releases December Advisory 5Health News:UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes 2Health News:UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes 3Health News:UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes 4Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 2Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 3Health News:Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development 4Health News:New Data Show Delta Dental Continues Offering Largest Nationwide Network 2Health News:Half of Full-Time Employees Surveyed Don't Understand Health Insurance Coverage for Cancer-Related Medical Expenses 2Health News:Half of Full-Time Employees Surveyed Don't Understand Health Insurance Coverage for Cancer-Related Medical Expenses 3Health News:Half of Full-Time Employees Surveyed Don't Understand Health Insurance Coverage for Cancer-Related Medical Expenses 4Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 2Health News:WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings 3
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... BZK Swabsticks contain 0.13% ... are available in Triple ... may be used whenever ... is needed. Typically, this ...
... PVP-I Prep Swabsticks are saturated with a ... 1% available iodine. Povidone Iodine is virtually ... It is also non-staining to the skin ... kill microbes on contact; they are sturdy ...
BETADINE® Solution Swabsticks are indicated whenever a topical microbicide is applied most conveniently with a swabstick....
Medicine Products: